Literature DB >> 20429823

Burden of illness of diabetic macular edema: literature review.

Er Chen1, Mark Looman, Marianne Laouri, Meghan Gallagher, Karen Van Nuys, Darius Lakdawalla, Joan Fortuny.   

Abstract

OBJECTIVE: To provide an overview of the literature on the burden of diabetic macular edema (DME) in the United States and selected European countries. RESEARCH DESIGN AND METHODS: Computerized searches of English-language literature were conducted in PubMed/MEDLINE (1980-2009). The searches were supplemented with electronic and manual searches of relevant society/association proceedings and bibliographies of electronically identified sources. Abstracts were reviewed for relevance to any of the following topics: epidemiology, including prevalence and incidence; health outcomes; resource use and treatment patterns; and economic and humanistic burden associated with DME. Relevant full text articles were retrieved and major findings were synthesized and compared within and across countries.
RESULTS: A total of 400 citations were included in the initial review. After abstract screening, 47 articles were deemed pertinent and summarized in this review. The prevalence of DME among diabetic patients ranged from 0.85% to 12.3% across the countries studied. The prevalence and incidence of DME vary depending on type of diabetes (1 vs. 2), insulin- vs. non-insulin-dependence, and duration of disease (years since diagnosis). Although literature findings are limited and indicate a need for further investigation, a synthesis of the available results indicates that DME has a negative impact on patients' health-related quality of life. In addition, patients with DME consume significantly more healthcare resources and incur higher costs compared to diabetic patients without retinal complications.
CONCLUSIONS: There remains a need for consistent data capture and assessment within and between countries included in this analysis. Despite the limited evidence, DME appears to be a costly disease that has a negative impact on patients' quality of life.

Entities:  

Mesh:

Year:  2010        PMID: 20429823     DOI: 10.1185/03007995.2010.482503

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  45 in total

1.  Fully automatic software for retinal thickness in eyes with diabetic macular edema from images acquired by cirrus and spectralis systems.

Authors:  Joo Yong Lee; Stephanie J Chiu; Pratul P Srinivasan; Joseph A Izatt; Cynthia A Toth; Sina Farsiu; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

Review 2.  New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel.

Authors:  F Bandello; J Cunha-Vaz; N V Chong; G E Lang; P Massin; P Mitchell; M Porta; C Prünte; R Schlingemann; U Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

Review 3.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 4.  Ranibizumab: in diabetic macular oedema.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

5.  Current treatments in diabetic macular oedema: systematic review and meta-analysis.

Authors:  John Alexander Ford; Noemi Lois; Pamela Royle; Christine Clar; Deepson Shyangdan; Norman Waugh
Journal:  BMJ Open       Date:  2013-03-01       Impact factor: 2.692

6.  Ten years of anti-vascular endothelial growth factor therapy.

Authors:  Napoleone Ferrara; Anthony P Adamis
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

7.  Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.

Authors:  Joshua D Stein; Paula Anne Newman-Casey; David D Kim; Kristen Harris Nwanyanwu; Mark W Johnson; David W Hutton
Journal:  Ophthalmology       Date:  2013-05-01       Impact factor: 12.079

Review 8.  Neuroprotection in diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 9.  The relationship between diabetic retinopathy and psychosocial functioning: a systematic review.

Authors:  Krystal Khoo; Ryan E K Man; Gwyn Rees; Preeti Gupta; Ecosse L Lamoureux; Eva K Fenwick
Journal:  Qual Life Res       Date:  2019-03-16       Impact factor: 4.147

Review 10.  Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.

Authors:  Olga Simó-Servat; Cristina Hernández; Rafael Simó
Journal:  Mediators Inflamm       Date:  2012-09-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.